Trisalus Life Sciences, Inc. (TLSIW) — 10-Q Filings

10-Q Filings (6)

• TriSalus Revenue Jumps 51%, But Net Loss Widens Amid High Costs — Nov 13, 2025 Risk: high
  TriSalus Life Sciences, Inc. (TLSIW) reported a significant increase in revenue for the nine months ended September 30, 2025, reaching $31.946 million, up from
• TriSalus Revenue Jumps 52% Amidst Mounting Losses, Cash Infusion — Aug 12, 2025 Risk: high
  TriSalus Life Sciences, Inc. (TLSIW) reported a significant increase in revenue for the three months ended June 30, 2025, reaching $11.213 million, up from $7.3
• TriSalus Life Sciences Files Q1 2025 10-Q — May 15, 2025 Risk: low
  TriSalus Life Sciences, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including common stock, preferred st
• TriSalus Life Sciences Files 10-Q for Q3 2024 — Nov 14, 2024 Risk: medium
  TriSalus Life Sciences, Inc. filed a 10-Q for the period ending September 30, 2024. The company, formerly MedTech Acquisition Corp, is incorporated in Delaware
• TriSalus Life Sciences Files Q2 2024 10-Q — Aug 14, 2024 Risk: medium
  TriSalus Life Sciences, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results and operational updates. Key financial d
• TriSalus Life Sciences Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: medium
  TriSalus Life Sciences, Inc. (TLSIW) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. TriSalus Life Sciences, Inc. filed a 10-Q report for the peri

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX